OverviewChartNewsTraderScreen

BVT Discount Zert BIIB 28.06.2024/  DE000VM17K57  /

EUWAX
24/05/2024  08:38:26 Chg.-0.82 Bid21:59:38 Ask21:59:38 Underlying Strike price Expiration date Option type
190.80EUR -0.43% -
Bid Size: -		 -
Ask Size: -		 Biogen Inc - USD 28/06/2024 Call
GlobeNewswire 03:00 BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire 02:18 Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against...
GlobeNewswire 24/05 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire 24/05 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 23/05 SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Con...
GlobeNewswire 23/05 Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biogen, Inc. (BIIB...
GlobeNewswire 23/05 BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire 22/05 Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Im...
GlobeNewswire 21/05 Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
GlobeNewswire 16/05 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 16/05 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire 15/05 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 09/05 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 08/05 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 07/05 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 02/05 Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 29/04 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 25/04 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 24/04 US closes mixed with earnings in limelight
TeleTrader 24/04 Biogen posts Q1 revenue of $2.3 billion
TeleTrader 24/04 US mostly up premarket with earnings in focus
GlobeNewswire 23/04 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
TeleTrader 21/04 Weekly Preview: Key earnings reports expected